home / stock / tcrr / tcrr quote
Last: | $ |
---|---|
Change Percent: | -0.93% |
Open: | $14.00 |
Close: | $13.81 |
High: | $14.114 |
Low: | $13.3186 |
Volume: | 57,677 |
Last Trade Date Time: | 02/12/2020 04:39:55 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $14.00 | $13.81 | $14.114 | $13.3186 | 57,677 | 02-12-2020 |
$ | $15.20 | $13.94 | $15.20 | $13.81 | 94,478 | 02-11-2020 |
$ | $15.50 | $15.06 | $15.50 | $14.85 | 75,274 | 02-10-2020 |
$ | $15.37 | $15.19 | $15.48 | $14.8452 | 46,870 | 02-07-2020 |
$ | $15.22 | $15.40 | $15.62 | $14.91 | 68,525 | 02-06-2020 |
$ | $15.64 | $15.01 | $15.90 | $14.91 | 67,844 | 02-05-2020 |
$ | $15.50 | $15.60 | $15.63 | $15.00 | 54,110 | 02-04-2020 |
$ | $15.00 | $15.44 | $15.68 | $14.91 | 38,748 | 02-03-2020 |
$ | $15.03 | $14.68 | $15.1168 | $14.555 | 40,038 | 01-31-2020 |
$ | $15.19 | $14.97 | $15.381 | $14.50 | 74,495 | 01-30-2020 |
$ | $15.19 | $15.08 | $15.6605 | $14.79 | 56,762 | 01-29-2020 |
$ | $15.67 | $15.04 | $16.5701 | $15.00 | 51,914 | 01-28-2020 |
$ | $16.01 | $15.27 | $16.23 | $15.27 | 82,768 | 01-27-2020 |
$ | $14.86 | $16.01 | $16.21 | $14.77 | 107,743 | 01-24-2020 |
$ | $13.54 | $14.57 | $14.8084 | $13.01 | 171,712 | 01-23-2020 |
$ | $13.95 | $12.95 | $14.06 | $12.70 | 71,039 | 01-22-2020 |
$ | $14.12 | $13.84 | $14.59 | $13.62 | 68,155 | 01-21-2020 |
$ | $15.00 | $14.08 | $15.00 | $14.00 | 117,579 | 01-20-2020 |
$ | $15.00 | $14.08 | $15.00 | $14.00 | 117,579 | 01-17-2020 |
$ | $14.64 | $14.75 | $15.31 | $14.55 | 70,410 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
TCR2 Therapeutics Inc. Company Name:
TCRR Stock Symbol:
NYSE Market:
CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR) (TCR 2 or the Company), a clinical-stage cell therapy company with a pipeline of novel next-generation T cell therapies for patients suffering from solid tumors, today announced financial results for...
NEW YORK, NY / ACCESSWIRE / April 13, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Univar Solutions Inc. (NYSE:UNVR)'s ...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Radius Global Infrastructure, Inc....